We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
26
AT&T
T
$165B
$46M 0.57%
1,640,974
-268,611
-14% -$6.44M
ORCL icon
27
Oracle
ORCL
$331B
$45.8M 0.57%
780,171
-62,372
-7% -$3.37M
ARRY
28
DELISTED
Array Biopharma Inc
ARRY
$45.8M 0.57%
992,510
-612,970
-38% -$17.2M
CRM icon
29
Salesforce
CRM
$134B
$43.1M 0.54%
285,351
+13,931
+5% +$2.18M
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.07T
$42.9M 0.53%
168,947
-23,933
-12% -$4.95M
PYPL icon
31
PayPal
PYPL
$49.5B
$42.4M 0.53%
371,763
-45,263
-11% -$5.02M
JPM icon
32
JPMorgan Chase
JPM
$939B
$42.3M 0.53%
380,269
-30,741
-7% -$3.39M
UNH icon
33
UnitedHealth
UNH
$382B
$42.2M 0.53%
173,655
-29,677
-15% -$7.14M
ADBE icon
34
Adobe
ADBE
$89.5B
$42.2M 0.53%
143,729
-54,957
-28% -$15.3M
GOOG icon
35
Alphabet (Google) Class C
GOOG
$3.9T
$40.5M 0.5%
752,120
-16,980
-2% -$980K
ABBV icon
36
AbbVie
ABBV
$458B
$39.5M 0.49%
545,119
-21,394
-4% -$1.68M
TSM icon
37
TSMC
TSM
$2.09T
$39.2M 0.49%
1,006,293
-79,212
-7% -$3.26M
BMRN icon
38
BioMarin Pharmaceuticals
BMRN
$11.5B
$38M 0.47%
445,930
-13,922
-3% -$1.19M
C icon
39
Citigroup
C
$222B
$37.9M 0.47%
487,480
-135,619
-22% -$9.07M
AXP icon
40
American Express
AXP
$223B
$37.6M 0.47%
294,071
-74,761
-20% -$8.78M
ROK icon
41
Rockwell Automation
ROK
$51.4B
$36.8M 0.46%
225,726
+3,173
+1% +$536K
MA icon
42
Mastercard
MA
$477B
$35.8M 0.45%
135,871
-9,499
-7% -$2.38M
XYL icon
43
Xylem
XYL
$28.5B
$35.6M 0.44%
427,820
+170,552
+66% +$13.6M
RARX
44
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$35.3M 0.44%
1,178,000
+154,000
+15% +$3.53M
ADSK icon
45
Autodesk
ADSK
$44.3B
$34.3M 0.43%
211,581
+36,685
+21% +$6.17M
TAL icon
46
TAL Education Group
TAL
$5.71B
$34.3M 0.43%
902,945
-63,055
-7% -$2.28M
KO icon
47
Coca-Cola
KO
$354B
$34M 0.42%
641,371
+150,781
+31% +$7.39M
TJX icon
48
TJX Companies
TJX
$170B
$33.9M 0.42%
608,113
+133,091
+28% +$7.07M
INCY icon
49
Incyte
INCY
$23.5B
$33.4M 0.42%
394,496
-99,439
-20% -$7.98M
AVGO icon
50
Broadcom
AVGO
$1.82T
$33M 0.41%
1,151,900
-83,740
-7% -$2.44M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.